CMUH –Department of Internal Medicine, Division of Chest Medicine Director Zhi-Yen Tu stated that lung cancer can be divided into non-small cell lung cancer and small cell lung cancer, with 85% of the patients belonging to non-small cell lung cancer.

There have been three major revolutions in the development of treatments for lung cancer: chemotherapy; targeted therapy; and currently immunotherapy.